LIVZON PHARMA - Announcement of the resolution of the third holders meeting of the second phase of the medium and long-term business partner stock ownership plan of Livzon Pharmaceutical Group Co., Ltd.
Overseas regulatory announcement
This announcement is made in accordance with Rule 13.10B of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited.
The "Announcement on the Resolution of the Third Holders' Meeting of the Second Phase of the Medium and Long-term Business Partner Stock Ownership Plan of Livzon Pharmaceutical Group Co., Ltd." published by Livzon Pharmaceutical Group Co., Ltd. on the website of the Shenzhen Stock Exchange is for reference only.
By order of the board of directors
Livzon Pharmaceutical Group Co., Ltd.
LivzonPharmaceuticalGroupInc.*
company secretary
Liu Ning
China, Zhuhai
April 23, 2026
As of the date of this announcement, the company’s executive directors are Mr. Tang Yanggang (vice chairman); the company’s non-executive directors are Mr. Zhu Baoguo (chairman), Mr. Lin Nanqi and Mr. Qiu Qingfeng; the company’s employee directors are Ms. Ran Yongmei; and the company’s independent non-executive directors are Mr. Bai Hua, Mr. Luo Huiyuan, Ms. Cui Lijie and Ms. Wang Zhiyao.
*Identification only
Securities code: 000513, 01513 Securities abbreviation: Livzon Group, Livzon Pharmaceutical Announcement Number: 2026-36 Livzon Pharmaceutical Group Co., Ltd.
The second phase of the medium- and long-term business partner stock ownership plan
Announcement of Resolutions of the Third Holders’ Meeting
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete, and contains no false records, misleading statements or major omissions.
- Convening of shareholders’ meeting
The third holders' meeting of the second-phase shareholding plan (hereinafter referred to as the "second-phase shareholding plan") of the medium- and long-term business partner shareholding plan of Livzon Pharmaceutical Group Co., Ltd. (hereinafter referred to as the "Company") was held on April 22, 2026 by means of communication voting. There were 78 holders who should attend this meeting, and 70 holders actually attended, representing 56.390028 shares of the second phase of the shareholding plan, accounting for 86.80% of the total shares of the company's second phase of the shareholding plan. The convening, holding and voting procedures of this meeting are in compliance with the "Second Phase Stock Ownership Plan of Livzon Pharmaceutical Group Co., Ltd.'s Medium and Long-term Business Partner Stock Ownership Plan (Revised Draft)", "Administrative Measures for the Second Phase Stock Ownership Plan of Livzon Pharmaceutical Group Co., Ltd.'s Medium and Long-term Business Partner Stock Ownership Plan (Revised Draft)" and relevant laws and regulations. The resolutions formed at the meeting are legal and valid.
- Review and voting status of the holders’ meeting
This meeting reviewed and approved the following proposals by registered vote:
(1) Consideration and approval of the "Proposal on Changing the Members of the Management Committee of the Second Phase of the Stock Ownership Plan"
In view of the fact that Mr. Tang Yanggang, Ms. Si Yanxia, and Mr. Yang Liang, the original members of the management committee of the company's second phase stock ownership plan, resigned from their positions due to job changes, retirement, personal development and other reasons, in order to ensure the smooth operation of the current phase of the share ownership plan, it was agreed to by-elect Mr. Liu Daping, the company's president, Ms. Liu Ning, secretary of the board of directors, and Mr. Wang Sheng, chief financial officer, to serve as members of the management committee of the second phase of the stock ownership plan, with terms consistent with the duration of the second phase of the stock ownership plan.
The above-mentioned proposed personnel do not hold positions in the company's controlling shareholder or actual controller, and have no relationship with shareholders, actual controllers, other directors and senior managers who hold more than 5% of the company's shares.
Voting results: 56,390,028 shares were approved, accounting for the total shares held by holders present at the meeting
100.00%%; 00,000 votes against, accounting for 0%; 00,000 votes abstaining, accounting for 0%.
(2) Consideration and approval of the amendments to the terms of the "Proposal on Adjusting the Related Content of the Second-Phase Stock Ownership Plan and Extending the Duration Period": The terms of the extension of the duration period in the second-phase stock ownership plan and management measures were revised to delete the constraint "within 10 days before the expiration of the duration period". The revised terms are: "If all the shares are not sold before the expiration of the duration of the current share ownership plan, the duration of the current share ownership plan can be extended with the approval of more than 2/3 of the valid voting rights present at the holders' meeting and upon review and approval by the board of directors."
Extension of the duration: In view that the duration of the second phase of the employee stock ownership plan is about to expire, based on confidence in the company's future development, and in order to effectively play the purpose and incentive effect of the implementation of the employee stock ownership plan, it is agreed to extend the duration of the second phase of the stock ownership plan by 12 months to August 12, 2027.
Except for the above adjustments, other contents of the current share ownership plan remain unchanged.
Voting results: 56.390028 votes in favor, accounting for 100.00% of the total shares held by holders present at the meeting; 00,000 votes against, accounting for 0%; 00,000 votes abstained, accounting for 0%.
The proposal still needs to be submitted to the company's board of directors for review.
- Other instructions
The matters resolved at this shareholders' meeting are in compliance with the "Guiding Opinions on the Pilot Implementation of Employee Stock Ownership Plans by Listed Companies", "Shenzhen Stock Exchange Self-Regulatory Guidelines for Listed Companies No. 1 - Standardized Operations of Main Board Listed Companies" and relevant documents on the company's stock ownership plan. The review procedures are legal and compliant. The company will continue to fulfill its information disclosure obligations in accordance with regulations. Investors are kindly requested to pay attention to subsequent announcements and pay attention to investment risks.
- Documents available for inspection
Resolution of the third holders meeting of the second phase of the company's medium and long-term business partner stock ownership plan. Announcement is hereby made.
Board of Directors of Livzon Pharmaceutical Group Co., Ltd.
April 24, 2026